Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Cardiovascular Drugs and Therapy|July 6, 2020
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel PharmacogenomicsJoel A Morales-Rosado, Kashish Goel, Lingxin Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genesBrooke L Fridley, Gregory D Jenkins, Ya-Yu Tsai, et al.
Translational Psychiatry|January 11, 2018
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomicsDuan Liu, Balmiki Ray, Drew R Neavin, et al.
Circulation Research|October 6, 2023
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of <i>CDCP1</i> and Cardiac FibrosisDuan Liu, Min Wang, Vishakantha Murthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast CancerPeter A Fasching, Duan Liu, Steve Scully, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
Nature Communications|April 25, 2025
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome SequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
The Lancet. Neurology|May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Nature Genetics|March 13, 2026
A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusionsWouter De Coster, Marleen Van den Broeck, Matt Baker, et al.
Pageof 10